| INK Ultra Money Free |
Latest 10 SEC filings (by transaction date) for DAWN within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jun 23/22 | Jun 21/22 | Gladstone Michael | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Ramasastry Saira | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Josey John A. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Holles Natalie C. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Grant Papanek Julie | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Garland J. Scott | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Becker Daniel J. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 22/22 | Jun 17/22 | Atlas Venture Opportunity Fund II, L.P. | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 766,667 | $15.00 |
Jun 22/22 | Jun 17/22 | Gladstone Michael | Indirect Ownership | Common Stock | P - Open market or private purchase ![]() | 766,667 | $15.00 |
Jun 21/22 | Jun 17/22 | AI Day1 LLC | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 1,200,000 | $15.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for DAWN within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jun 23/22 | Jun 21/22 | Gladstone Michael | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Ramasastry Saira | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Josey John A. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Holles Natalie C. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Grant Papanek Julie | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Garland J. Scott | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 23/22 | Jun 21/22 | Becker Daniel J. | Direct Ownership | Director Stock Option (Right to buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) ![]() | 28,700 | |
Jun 22/22 | Jun 17/22 | Atlas Venture Opportunity Fund II, L.P. | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 766,667 | $15.00 |
Jun 22/22 | Jun 17/22 | Gladstone Michael | Indirect Ownership | Common Stock | P - Open market or private purchase ![]() | 766,667 | $15.00 |
Jun 21/22 | Jun 17/22 | AI Day1 LLC | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 1,200,000 | $15.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Moderna (OQ:MRNA) |
United Therapeutics (OQ:UTHR) |
Charles River Laboratorie (N:CRL) |